Ascendis Pharma A/S Announces Full Year 2019 Financial Results and Business Update Conference Call on April 1

Ads

You May Also Like

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company Horizon out-licenses proprietary cell ...

Athenex, Inc. Announces Second Quarter 2017 Results

Received Chinese FDA approval to begin clinical trials of KX-02 Tablet for GlioblastomaBegan patient ...